CD8 + T cells are key members of the adaptive immune response against infections and cancer. As we discuss in this review, these cells can present diverse metabolic requirements, which have been intensely studied during the past few years. Our current understanding suggests that aerobic glycolysis is a hallmark of activated CD8 + T cells, while naive and memory (T mem ) cells often rely on oxidative phosphorylation, and thus mitochondrial metabolism is a crucial determinant of CD8 + T mem cell development. Moreover, it has been proposed that CD8 + T mem cells have a specific requirement for the oxidation of long-chain fatty acids (LC-FAO), a process modulated in lymphocytes by the enzyme CPT1A. However, this notion relies heavily on the metabolic analysis of in vitro cultures and on chemical inhibition of CPT1A. Therefore, we introduce more recent studies using genetic models to demonstrate that CPT1Amediated LC-FAO is dispensable for the development of CD8 + T cell memory and protective immunity, and question the use of chemical inhibitors to target this enzyme. We discuss insights obtained from those and other studies analyzing the metabolic characteristics of CD8 + T mem cells, and emphasize how T cells exhibit flexibility in their choice of metabolic fuel.
| INTRODUC TI ON
In this review, we will explore the latest advancements in the understanding of the metabolic requirements of CD8 + T cells, with a particular focus on the metabolism of fatty acids. The increasing availability of mouse models targeting metabolic enzymes and transcription factors has provided new tools to reliably establish the role of metabolic checkpoints in the function of immune cells in vivo, complementing-and sometimes challenging-the knowledge previously obtained from the use of chemical inhibitors. We will critically examine the work that has led to the current understanding of CD8 + T mem cell metabolism, and discuss recent studies that describe how cellular metabolism correlates with or influences the establishment of immune memory, while emphasizing the functional and metabolic diversity found among different types of memory cells and their potential for therapy and human medicine.
| CD8 + T CELL IMMUNIT Y
The development of the immune response mediated by CD8 + T cells can be characterized by 3 main stages. 1, 2 During the initial phase, naive T cells that circulate through secondary lymphoid organs are met and activated by antigen-presenting cells (APCs) displaying antigens from a pathogen in the context of MHC molecules, and this is accompanied by a remarkable increase in cell size and metabolic activity. An extensive clonal expansion follows, with cell divisions occurring as often as every 4 hours, 1 generating cells that differentiate into cytotoxic T lymphocytes (CTLs). CTLs migrate to the sites of infection to fight the pathogen through production and targeted release of granzymes and perforins to infected cells, and the secretion of cytokines such as TNF or IFNγ that stimulate the immune system and activate macrophages to phagocytose infected and dying cells. At the peak of the response, most cells exhibit an activated phenotype characterized by the production of cytokines, high KLRG1 expression (as a marker of terminal effector differentiation) and a short lifespan. Once the pathogen is cleared, TCR and cytokine stimulation are interrupted and most activated cells die by apoptosis, resulting in a massive reduction in their number. Only a small percentage (about 5%-10%) persist as long-lived memory cells, 1, 3 with the potential to quickly proliferate in response to a new infection by the same pathogen.
The population of CD8 + T mem cells that survive after the initial immune response is heterogeneous, consisting of different types of cells that differ in their function, longevity, and location. 4, 5 Long- lived "central" memory T cells (T CM ) present increased expression of the IL-7 receptor alpha (IL7ra also known as CD127), 6 the lymphnode homing selectin CD62L, the chemokine receptor CCR7, and have reduced immediate production of effector cytokines such as IFNγ. The longevity of the T CM cell population is partly due to the expression of the antiapoptotic protein Bcl-2, telomerase activity and sustained homeostatic proliferation. 7 Importantly, these cells have the capacity to produce IL-2 and robustly proliferate upon secondary activation. In contrast, effector memory CD8 + T cells (T EM ), comprising another population that also survives the primary immune response, exhibit low expression of CD62L and CCR7, high expression of KLRG1, and display effector activity (eg, cytotoxic activity and the production of cytokines). T EM are usually present in non-lymphoid tissues and unlike T CM , have a low proliferative potential upon secondary activation. 7, 8 More recently, a third group of CD8 + T mem cells located in the epithelial barrier, as well as in mucosal and adipose tissues, has been described. These tissue resident memory cells (T RM ) can respond to pathogens quickly and independently of cells recruited from the circulation, present a characteristic CCR7 low CD69 hi CD27 low phenotype and settle in tissues due to their expression of tissue-homing chemokine receptors and adhesion molecules. [9] [10] [11] This classification of CD8 + T mem cell subsets is not absolute, and there are cells that are found after the resolution of the immune response that do not belong to any group. Rather, differentiation of cells after infection results in a spectrum of phenotypic characteristics, from cells with greater longevity and memory potential, to short-lived effector cells that are terminally differentiated-with variants in between. 4 The cues that guide development of CD8 + T mem cells are not completely understood but models of T cell diversification indicate that the potential of activated cells to give rise to CD8 + T mem populations is most probably not predetermined in naive cells, but it is likely to result from a combination of intrinsic and extrinsic signals that respond to the time, the intensity and the specific conditions during the activation of a CD8 + T cell. 2, 4 Cytokines such as IL-15 and IL-7, which provide indispensable survival signals to naive T cells, [12] [13] [14] also promote the survival of CD8 + T mem cells. On the one hand, expression of the IL-7 receptor subunit CD127 correlates with survival and expression of Bcl-2. [12] [13] [14] [15] On the other hand, IL-15 favors CD8 + T mem homeostatic proliferation and mice lacking IL-15 or the IL-15 receptor alpha chain (IL-15rα) develop fewer polyclonal CD8 + T mem cells. 16, 17 In the absence of both cytokines, essentially no CD8 + T mem cells are formed after an infection. 1 As we will discuss in this review, it has been lately proposed that these cytokines can influence the development of the different memory subsets by promoting specific metabolic changes, particularly during the transition between the peak of the effector phase and the establishment a of long-lived memory population. The mechanisms behind this metabolic modulation have not been fully characterized yet, and are thus a subject of intense study.
| ME TABOLI C CHANG E S DEFINING CD8 + T CELL IMMUNIT Y

| Naive T cell metabolism
The metabolic demands of T n cells are relatively low and focused on maintaining homeostatic proliferation and supporting cellular migration. [18] [19] [20] A preferred source of energy for T n cells is glucose that through glycolysis is first processed into pyruvate, which is transported into the mitochondria and decarboxylated into acetyl-CoA ( Figure 1 ). Acetyl-CoA can then be incorporated into the tricarboxylic acid (TCA) cycle, where it is completely oxidized into CO 2 . This process generates NADH and FADH 2 , reduced molecules that transfer electrons to the mitochondrial electron transport chain (ETC), resulting in the synthesis of ATP and consumption of O 2 during oxidative phosphorylation (OxPhos). Through this pathway, cells can maximize the energy output of glucose, calculated as up to 36 molecules of ATP for each molecule of substrate, while maintaining cellular redox balance by regenerating the necessary NAD + and FAD through oxidation in the mitochondria. 20 Tonic signals from IL-7 and the TCR are crucial for the survival of T n cells partly by sustaining the uptake of glucose used in mitochondrial respiration. Therefore, cytokine withdrawal that results in T n cell atrophy and death also causes a loss of mitochondrial membrane potential and cellular ATP even in the presence of high levels of extracellular nutrients. 13, 18, 21, 22 Glucose is not the only nutrient used by T n cells, which can also oxidize external lipids like oleate and palmitate in their mitochondria. 23, 24 To this end, T n cells express enzymes that support the oxidation of longchain fatty acids (LCFAs), 25 and metabolomic analysis of these cells found abundant acylcarnitine molecules, which correlate with this process. 24, 26 
| Upregulation of aerobic glycolysis upon T cell activation
Signaling through the TCR receptor and co-stimulatory molecules (such as CD28 and cytokine receptors) in T cells leads to the activation of immunological pathways which are accompanied by a profound alteration in the cellular metabolism to support their proliferation and effector function. [27] [28] [29] [30] [31] [32] One crucial step taken by T cells to sustain this enhanced metabolism is to augment their uptake of glucose through the increased expression of members of the solute carrier family 2 (Slc2, also known as Glut). Glut1 (Slc2a1) was the first glucose transporter described to be upregulated by costimulatory signals from CD28 30 and to be essential for the activation of CD4 + T eff cells. 33 CD8 + T cells also increase the expression of the transporter Glut3 and are thus less reliant on Glut1 for their activation. 33, 34 Glucose is taken up and metabolized into 2 molecules of pyruvate through the process of glycolysis ( Figure 1 ), which in addition yields 2 molecules of ATP and reduced NADH. Yet, in contrast to resting cells, most of the produced pyruvate and NADH in activated T cells is not oxidized in the mitochondria, but is reduced into lactate by the enzyme lactate dehydrogenase (Ldha) and excreted from the cell. This process is named aerobic glycolysis, or Warburg effect after the German Nobel laureate Otto Warburg who described this behavior in activated leukocytes 60 years ago, 35 and has been extensively described in T cells ever since. 28, [36] [37] [38] It should be pointed out, however, that activation of T cells does not lead to a complete switch from mitochondrial respiration toward aerobic glycolysis. Instead, OxPhos is upregulated but to a lesser extent than aerobic glycolysis. Indeed, mitochondrial oxidation plays an important role in T cell activation, as evidenced by the deleterious effects that inhibiting mitochondrial function has on T eff differentiation. [39] [40] [41] Although inherently inefficient to produce ATP, aerobic glycolysis is required for T cells to engage in productive growth and cytokine production. Part of the pyruvate and glycolytic intermediaries are shuttled toward the synthesis of biomolecules, and the reduction of pyruvate to lactate allows the regeneration of oxidized NAD + , indispensable to continue with the glycolytic process. Moreover, it has been described that, in the absence of substrate, the glycolytic enzyme glyceraldehyde 3-phosphate dehydrogenase (GAPDH) can repress the translation of IFNγ. 37 Therefore, an active glycolytic function, which would signal favorable nutrient availability, engages GAPDH and thus positively regulates the acquisition of an effector phenotype. This alternative function regulating gene expression (referred to as "moonlighting") is observed for several metabolic enzymes, and provides an intriguing mechanism by which cells can respond to specific metabolic conditions. 31, 42 As we will describe, the glycolytic pathway is actively coordinated by several molecules that are of great importance for the successful activation and proliferation of T eff cells.
| Molecular regulation of metabolism during T cell activation
One of the most studied orchestrators of the cellular metabolism that characterizes activated T cells is the mechanistic (formerly mammalian) target of rapamycin (mTOR), a serine/threonine kinase that plays a key role in regulating cellular growth, proliferation, and survival (reviewed in 43). mTOR acts as the catalytic subunit of 2 complexes: mTOR complex 1 (mTORC1) and mTORC2 that have different cellular functions. mTORC1 is composed of 3 core components: mTOR, Raptor (regulatory protein associated with mTOR), and mLST8 (mammalian lethal with Sec13 protein 8), while mTORC2 contains mTOR, Rictor (rapamycin insensitive companion of mTOR), and mLST8.
Activation of mTORC1 follows TCR and CD28 stimulation through PI3K and Akt signaling ( Figure 1 ). 44, 45 Activated Akt inhibits the key negative regulator of mTORC1 known as tuberous sclerosis complex (TSC) by phosphorylating one of its members, TSC2.
This prevents TSC from functioning as a GTPase-activating protein (GAP) for the RAS homolog enriched in brain (Rheb), which is a small GTPase with a crucial function in activating mTORC1. Therefore, deletion of TSC2 results in CD8 + T cells that have constitutive activity F I G U R E 1 Overview of metabolic pathways regulated during T cell differentiation. Immune signals from the TCR, co-stimulatory molecules, and cytokine receptors activate PI3K and thus the tyrosine kinase AKT. Active AKT phosphorylates and inhibits the tuberous sclerosis complex (TSC), stimulating the activity of mTORC1. mTORC1 stimulates aerobic glycolysis and lipid synthesis indirectly through supporting the activity of transcription factors like MYC, HIF1, and SREBP that promote the expression of key enzymes in these processes. The AMP-activated-protein kinase (AMPK) is activated by high AMP and ADP (signaling metabolic stress) and antagonizes mTORC1 activity by stabilization of the repressor TSC and inhibition of the mTORC1 subunit Raptor. AMPK also indirectly promotes mitochondrial biogenesis through the activity of the transcriptional coactivator PGC1α. Moreover, AMPK can inhibit the synthesis of fatty acids and stimulate the oxidation of long-chain fatty acids (LCFA) by blocking the production of malonyl-CoA by the acetyl-CoA carboxylase (ACC1/2), and thus also relieving the inhibition on carnitine palmitoyltransferase 1 (CPT1) by malonyl-CoA. CPT1 is the rate-controlling enzyme for the transport of LCFAs into the mitochondrial matrix, where they can be metabolized into acetyl-CoA and reduced molecules through fatty acid oxidation (FAO). Short-and medium-chain fatty acids (SCFAs and MCFAs) enter FAO independently of CPT activity. In CD8 + T cells, glucose enters the cell through the Glut1 and Glut3 glucose transporters and is converted into pyruvate through glycolysis. In resting cells, pyruvate dehydrogenase (PDH) in the mitochondria converts this pyruvate to acetyl-CoA, which is further oxidized in the tricarboxylic acid (TCA) cycle, together with acetyl-CoA obtained from FAO. The TCA cycle generates reduced NADH and FADH 2 , whose oxidation by members of the electron transport chain (ETC) consumes molecular oxygen (O 2 ) and supports the generation of ATP by oxidative phosphorylation (OxPhos). In activated cells, a major part of the pyruvate produced after glycolysis is reduced to lactate by the enzyme lactate dehydrogenase (LDHA), and much of the acetyl-CoA obtained in the mitochondria is shuttled to the cytoplasm to sustain lipid synthesis. PDK1, pyruvate dehydrogenase kinase 1; PPP, pentose phosphate pathway; HMGCR hydroxy-methyl-glutaryl-CoA reductase; FASN, fatty acid synthase; CACT, carnitine-acylcarnitine translocase; (V)LCAD, (very) long-chain acyl-CoA dehydrogenase; RHEB, RAS homolog enriched in brain; FABP, fatty acid-binding protein; PL, phospholipid; TAG, triacylglycerol; TRAF6, TNF-associated factor 6 inhibition of this complex with the bacterial compound rapamycin reduces T eff cell differentiation. 44, [46] [47] [48] [49] [50] [51] Due to this effect, rapamycin has been approved as an immunosuppressive treatment for kidney transplant since 1999. Rapamycin affects mTORC1 activity acutely but does not bind to or inhibit mTORC2, although reduced mTORC2 signaling has been observed during prolonged treatment, presumably due to an exclusion of mTOR bound to rapamycin from integrating into the mTORC2 complex. 43, 52 The activation of mTORC1 strongly correlates with the increased expression of enzymes and substrate transporters (notably Glut1 and Glut3) mediating glycolytic and specific biosynthetic pathways in CD8 + T cells. 34, 53 Mechanistically, the main targets of mTORC1 are the phosphorylation of p70S6 Kinase 1 (S6K1) and eIF4E-binding protein (4EBP) that prevents assembly of the eIF4F complex, necessary for the initiation of translation in eukaryotic cells. Thus, mTORC1 promotes protein biosynthesis, including that of transcription factors such as HIF1α, which together with the transcription factor Myc are indispensable mediators of the metabolism of activated T cells. 24, 34, 54, 55 Expression of Myc (also known as c-Myc) in T cells is upregulated within 3 hours after TCR stimulation. 24 Myc promotes the expression of Glut1, Glut3, hexokinase 2 (Hk2), and 6-phosphofructokinase (Pfkl) among others, which are all enzymes essential for glycolysis, as well for the pentose phosphate pathway (PPP) that mediates the synthesis of nucleotides and NADPH from glucose. 24 Myc can also support glutamine transport and metabolism, critical for activated T cells, through inducing the expression of glutaminase 2 (Gls2) and the glutamine transporter CD98. 24 Compared to wildtype cells, Myc-deficient CD8 + T cells present an impaired glycolytic flux and reduced accumulation of lipids, amino acids, and nucleotides, thus supporting the idea that this transcription factor is crucial for early metabolic reprogramming upon T cell activation. 56 Hypoxia-inducible factor 1 (HIF1) is a transcription factor composed of the subunits HIF1α and HIF1β (the latter also known as aryl hydrocarbon receptor (AHR) nuclear translocator, ARNT). HIF1α
is stabilized under hypoxic conditions and coordinates a switch from mitochondrial respiration to glycolysis to adapt to low oxygen availability. 55, 57 HIF1α is not required for the initial activation of T cells 53 but is highly expressed in T eff even in the presence of oxy- 
| ME TABOLI C COORD INATI ON OF CD8 + T M E M DE VELOPMENT
| Adaptation at the T eff to T mem transition
CD8 + T mem cells possess specific metabolic demands due to their role in the immune response, that requires them to persist for a long time through homeostatic proliferation and unlike naive cells do so without TCR stimulus. 2 The evidence so far suggests that upregulation of mitochondrial OxPhos is used to support ATP production and preserve redox balance, and is characteristic of at least the T CM subset of CD8 + T mem cells. 69, 70 Moreover, CD8 + T mem cells have the ability to swiftly and vigorously become activated upon re-stimulation, and to adopt an effector phenotype faster than naive cells. This has been attributed to a metabolic advantage that allows them to quickly react to increased energy demands, usually quantified as an augmented spare respiratory capacity (SRC). 71 SRC is a metabolic readout experimentally measured by uncoupling oxygen consumption from ATP synthesis, simulating a sudden increment in ATP demands like found upon TCR stimulation. In other words, the SRC tests the maximum capacity of the cell to rapidly oxidize substrates in the mitochondria to meet increased demand. Accordingly, it was described that CD8 + T mem cells obtained after infection have higher SRC and reduced extracellular acidification rate (ECAR, an indirect measurement of aerobic glycolysis) when compared to effector cells during the active immune response. 69, 70 Several studies have shown that mTORC1 activity is negatively related to the development of CD8 + T cell memory. 46, 47, [72] [73] [74] mTORC1 inhibition at the end of the effector phase favors the switch from aerobic glycolysis, characteristic of T eff cells, toward mitochondrial oxidation that supplies energy and protects cells from apoptosis after glucose or cytokine stimulation withdrawal. 46, 74 In vivo, reduced mTORC1 activity thus allows the generation of T cells that are better suited to survive the conclusion of the primary immune response, which is marked by a decrease of cytokine (eg, IL-2) and TCR survival signals including a reduction of glucose and amino acid uptake. 46 Accordingly, uncurbed activation of mTORC1 due to TSC2 deletion precludes the generation of a memory population after the primary response, while promoting the development of terminally differentiated effector cells with high expression of KLRG1 and the transcription factor T-bet, which directs differentiation into a CTL phenotype. 46 This defect can be reverted by rapamycin treatment during the contraction phase, demonstrating that a downregulation of mTORC1 activity after the peak of the immune response improves the survival of antigen-specific cells. 46, 72, 75 Nevertheless, mTORC1 is also necessary for the reactivation of CD8 + T mem cells. Deletion of the mTORC1 activator Rheb favors the survival after viral infection of antigen-specific T cells, which however fail to respond to restimulation and thus would not provide protective immunity. 46 Examination of asymmetric cell division during CD8 + T cell activation has provided more insights into the relationship between mTORC1 activity and memory development. Asymmetric division has been proposed to occur due to an uneven distribution of cytoplasmic components after the T cell division that follows the formation of the immune synapse between an APC and a CD8 + T cell.
This can lead to a daughter cell proximal to the APC which is more prone to differentiate into a CD8 + T eff cell, and a daughter cell distal to the APC with higher potential to develop into a CD8 + T mem cell. 76 Uneven distribution of mTORC1 activity between daughter cells after this first division was proposed to determine their effector vs memory fate, 77 with higher mTORC1 activity in the proximal cell that also presents a more glycolytic metabolism, along with enhanced expression of the Myc, Glut1 and the amino acid transporter CD98. 77, 78 In contrast to mTORC1, mTORC2 appears to be dispensable for the generation of CD8 + T eff cells, but can interfere with the development of memory by phosphorylating and inhibiting the nuclear translocation of the transcription factor Foxo1. 46, 79 Foxo1 promotes the expression of CD127, CD62L, SIP 1 , and CCR7 and thus mediates the survival and migration of T mem cells. 73, [80] [81] [82] Hence, CD8 + T cells with a deletion of the mTORC2 component Rictor have higher expression of T mem surface markers after primary infection in vivo. 46, 79 Moreover, mTORC2 was found to influence T mem metabolism and inhibit certain catabolic pathways. Because mTORC2 deletion does not impair CD8 + T cell effector function, selective inhibition of mTORC2 could be a strategy to improve CD8 + memory generation, without compromising the primary immune response. 79 
| AMPK controls metabolic adaptation
The studies mentioned above propose that, in contrast to their role in T cell activation, mTORC1 and mTORC2 have a negative influence over the transition from the effector to the memory phase of the immune response, through mechanisms that involve immune signaling and metabolic adaptation. Yet, how CD8 + T cells can actively coordinate mTOR activity and thus memory development at the molecular level is still not fully understood. One important negative regulator of mTORC1 that has been associated with T mem cell development is the AMP-activated protein kinase (AMPK) ( Figure 1 ) (recently reviewed in 83, 84) . AMPK is a heterotrimeric serine/threonine protein kinase composed of one catalytic α subunit, and regulatory β and γ subunits that is typically activated under metabolic stress (translated in high AMP and ADP concentrations) and modulates cellular metabolism by inhibiting anabolic and promoting catabolic metabolism. [85] [86] [87] [88] [89] Phosphorylation of the Thr172 in the AMPKα subunit by the kinase LKB1, together with the binding of ADP or AMP to the nucleotidebinding sites of the γ subunit activates AMPK in response to metabolic stress in T cells. [90] [91] [92] Deletion in T cells of AMPKα1 (the isoform of the catalytic subunit of AMPK found in lymphocytes) does not prevent the development or homeostasis of naive cells, but results in an increased basal mTORC1 activity, supporting the notion that AMPK antagonizes mTORC1. 90, [93] [94] [95] AMPK can restrain mTORC1 function through phosphorylation and activation of the negative regulator TSC2 96 as well as the mTORC1 member Raptor, 97 thus reducing protein translation and lipid synthesis and therefore energy expenditure. Moreover, AMPK inhibits de novo FAS by directly phosphorylating ACC1, and can also promote long-chain fatty acid oxidation (LC-FAO) through phosphorylation of ACC2, an isoform of ACC present in the outer mitochondrial membrane. 67, 98, 99 In addition, AMPK phosphorylates the kinase ULK1, 100 and hence stimulates the degradation of cellular components to provide nutrients by initiating autophagy, which is important for the development CD8 + T mem cells in vivo, 101 and promotes mitochondrial biogenesis through the activity of PPARγ coactivator-1α (PGC1α). 84, 102, 103 To study the role of AMPK on CD8 + T mem differentiation, Cantrell and colleagues evaluated the immune response to an infection with 
| THE ROLE OF LC-FAO IN CD8 + T M E M CELL S
| TRAF6-mediated signaling in CD8 + T mem development
The first data linking LC-FAO to CD8 + T mem cell development came from a pioneering study by Erika Pearce using mice with a T cell-specific deletion of the TNF-associated factor 6 (TRAF6). 106 TRAF6 is an adapter protein that is involved in mediating several protein-protein interactions and was originally identified as a mediator of interleukin-1 receptor-dependent activation of NF-κB. 109 TRAF6 expression is broad and important in several tissues, as witnessed by the fact that TRAF6 complete knockout mice do not survive more than 2 weeks after birth. 110 Studies using bone marrow chimeras showed that TRAF6 participates in many signaling pathways in immune cells, including those from members of the TNFR superfamily, tumor-growth factorβ receptors (TGFβR) and the TCR. 109 T cells strongly upregulate TRAF6 expression after TCR engagement and mice with a deletion of TRAF6 specifically in T cells generate CD4 + and CD8 + naive T cells with hypersensitivity to TCR stimulation and enhanced PI3K-Akt activation. 111 Moreover, these mice have a progressive autoimmune disease and by 10-12 weeks of age present splenomegaly and lymphadenopathy caused by hyperactivation and proliferation of B cells and activated CD4 + T cells with reduced susceptibility to suppression by CD4 + CD25 + regulatory T (T reg ) cells. Additionally, T cell-specific TRAF6-deficient mice exhibit excessive cytokine production that suggests an abnormal T-helper type 2 effector response. 109, 111 In contrast, naive CD8 + T cells have defects in their homeostatic or lymphopenia-induced proliferation and thus naive T cell-specific TRAF6-deficient mice have reduced numbers of CD8 + T cells in the periphery. 106, 111, 112 Despite this strong immune dysregulation that resembles a delayed scurfy autoimmune phenotype, it was reported that T cell-specific TRAF6-deficient mice can mount a normal primary immune response against an attenuated strain of LmOVA, but had a reduced CD8 + T mem population 60 days after infection. 106 However, in this model, an influence of the hyperactive CD4 + T cell compartment on the development of CD8 + T mem cells cannot be excluded.
To assess the intrinsic effects of TRAF6-deficiency in CD8 + T cells without the influence of the CD4 + T cell-driven autoimmunity, Pearce and colleagues then transferred TRAF6-deficient OT-I cells into a congenic host and followed their fate during infection with
LmOVA. They observed that these T cells could be activated normally and proliferate during the primary infectious challenge but failed to proliferate and survive upon re-infection. 106 Moreover, at the end of the primary response, CD8 + T cells displayed increased KLRG1 expression, a marker of terminally differentiated T eff cells, suggesting that TRAF6-deficient T cells had an intrinsic defect in adopting a memory phenotype. Surprisingly, despite TRAF6 modulating various signaling pathways, the authors identified specific genes related to FA metabolism differentially regulated between TRAF6-deficient and WT cells 10 days after infection, coinciding with the transition between the primary response and memory development. In vitro, WT OT-I activated cells subjected to IL-2 withdrawal increased the oxidation of palmitate, but TRAF6-deficient cells did not. It was interpreted from these data that the transition of CD8 + T cells from T eff to T mem state was dependent on a shift to catabolic metabolism, mediated by TRAF6 and LC-FAO, to promote survival in the face of diminishing growth signals and glucose metabolism.
To date it is still unclear how TRAF6 regulates LC-FAO in CD8 + T cells. 109 Pearce et al proposed that this effect was mediated by AMPK because, in contrast to WT cells, TRAF6-deficient OT-I T cells transferred in vivo presented lower AMPK activation at the peak of the primary response. 106 In vitro, TRAF6-deficient cells failed to activate AMPK in response to IL-2 withdrawal, but treatment with the biguanidine anti-diabetic drug metformin restored their AMPK activity and enhanced their oxidation of palmitate (as it is the case for other tissues 113 ), while improving T mem survival in vivo. However, metformin activates AMPK indirectly through the induction of metabolic stress by inhibiting complex I of the ETC, and thus mitochondrial respiration. [113] [114] [115] Metformin can also reduce mTORC1 signaling in T cells independently of AMPK. 115 Accordingly, treatment with rapamycin after the effector phase could rescue T mem survival, suggesting that TRAF6 deletion acted upstream of mTORC1. Therefore, metformin may exert FAO-and AMPK-independent effects on cellular metabolism to affect T mem cell development. (Figure 1 ). 116, 117 The first step of the transport is catalyzed by CPT1, an enzyme that can be found in 3 isoforms in different tissues. 117 CPT1A is the isoform found in liver, kidney, intestine, pancreas, and the only one described so far in primary T cells, according to publicly available data (immgen.org). CPT1B is expressed in heart, skeletal muscle, and testis; and CPT1C, the most recently characterized, is found primarily in brain, but has also been reported in tumor cell lines. [118] [119] [120] [121] The reaction catalyzed by CPT1 is ratecontrolling for the oxidation of LCFAs and involves the conjugation of the long-chain acyl group to carnitine. The resulting long-chain acylcarnitines can then be transported through the mitochondrial inner membrane into the matrix by CACT and restored by CPT2
| Control of LC-FAO
to acyl-CoAs, which can then be oxidized. and inhibition of ACC2, a mechanism known to be used by certain cell types, such as muscle or liver, to increase LC-FAO in response to fasting or increased energy demands. Accordingly, complete deletion of ACC2 in mice increases basal oxidation of LCFAs in muscle and reduces accumulation of fat, 98, 99, 125 which can be attributed to increased CPT1 activity and transport of LCFAs into the mitochondria for oxidation. It is, however, not clear if T cells also employ this mechanism to regulate their rates of LC-FAO,
given that ACC2 deletion in these cells has only very modest effects on FAO while not influencing their differentiation, effector function or memory development. 25, 62, 65, 126 Instead, transcriptional regulation of Cpt1a expression could be more relevant in T cells. Indeed, it has been reported that PI3K-Akt-mTORC2 signaling initiated by growth factor or TCR/CD28 stimulation induces a downregulation of Cpt1a expression, 25, 46, 127, 128 which in activated T cells is accompanied by a reduction of LC-FAO. 24 
| LC-FAO and the development of CD8 + T mem
Previous studies have suggested that, during the T eff to T mem transition, CD8 + T cells can specifically increase the expression of Cpt1a to adopt an oxidative metabolic program after the primary immune response, and that this expression correlates with T cell longevity and metabolic fitness upon re-stimulation. 46, 70 To convey this idea, it was shown that OT-I T cells transduced in vitro to overexpress Cpt1a and transferred into congenic hosts present an improved survival after LmOVA infection, even when transferred into IL-15-deficient mice, which suggests that CPT1A mediates longevity downstream of IL-15 signaling. 70 However, because of the difficulties in studying the T eff to T mem transition in vivo, much of the analysis done to further investigate this connection relies on the in vitro generation of T mem -like cells. 70, 71, [129] [130] [131] [132] This method involves the short-term activation of OT-I splenocytes with antigen, followed by antigen removal and incubation with IL-15 (or IL-7), and gives rise to CD8 + T cells with phenotypic characteristics that resemble ex vivo T CM cells. 129 In comparison with cells kept in IL-2 after antigen removal ("IL-2 T eff " cells), these in vitro-generated "IL-15 T mem -like cells" are more quiescent (with most cells in the G0/G1 phase of the cell cycle), express surface molecules found in T CM cells (such as CD44 and CD62L), downregulate CD69, CD25, and the production of IFNγ, and can be reactivated upon re-stimulation. 129 Their metabolism is also more oxidative than that of IL-2 T eff cells, as they present more mitochondrial mass, lower ECAR and higher SRC, similar to what has been observed in bona fide CD8 + T mem cells compared to ex vivo CD8 + T eff cells. 70 
IL-15 T mem -like cells have also higher expression
of Cpt1a, and their SRC is reduced after downregulation of Cpt1a mRNA levels using shRNA. 70 Moreover, overexpression of Cpt1a in activated CTLs was reported to increase their survival after transfer into a naive congenic recipient. 70, 71 Taken together, these observations may support the idea that, by upregulating the expression of Cpt1a, CD8 + T mem cells enhance mitochondrial oxidation by increasing the provision of LCFAs to the mitochondrial matrix, thus assuring a crucial supply of energy after the removal of TCR and cytokine stimulus. 32, 108, 133 However, it needs to be considered that although IL-15 T mem -like cells provide a simple in vitro system to study the influence of cytokines on the survival of activated cells after the removal of antigenic stimulation, this model does not completely reflect the in vivo conditions at the end of the effector and start of the memory phase. Thus, the cells generated with this method are not identical to the long-lived CD8 + T mem found after the peak of the primary immune response, 129 and may not reflect the metabolism of CD8 + T mem cells in an in vivo setting.
| CPT1A is dispensable for CD8 + T mem
To answer the question of whether LC-FAO mediated by CPT1A is critical for the development of CD8 + T mem cells, we generated T cellspecific Cpt1a conditional knockout mice. 25 In contrast to the phe- importantly, these mice generated a CD8 + T mem population that survived for weeks after the primary response, and robustly proliferated and produced IFNγ after re-challenge. 25 These data demonstrate that CPT1A-mediated transport of LCFAs into the mitochondria is not required for the development of immunological memory. Furthermore, the differentiation of CD4 + T reg cells, another T cell subset that has been described to depend on LC-FAO 19, 134 was unaffected by the absence of Cpt1a. 25 We also evaluated the memory response in mice deficient in other enzymes involved in LC-FAO, namely the long-chain acyl-CoA dehydrogenase (LCAD) and the very-long-chain acyl-CoA dehydrogenase (VLCAD), which catalyze the first step in the process of mitochondrial β-oxidation downstream of CPT1A. 124, 135, 136 These mice are models of human VLCAD-deficiency, which is the most common FAO disorder in patients 137, 138 and present an array of cardiac and hepatic disorders due to reduced FAO capacity that are acutely manifest upon fasting or cold exposure. 138 LCAD-and VLCADdeficient mice vaccinated with mouse-adapted H3N2 influenza could generate a protective response against H1N1 influenza, due to a normal T cell memory response. 25 These results obtained from genetic mouse models of LC-FAO deficiency challenge previous reports using IL-15 T mem -like cells suggesting that inhibition of CPT1 with the oxirane carboxylic acid etomoxir reduces the survival of CD8 + T mem cells 70 and impairs differentiation of T reg cells. 134 This discrepancy thus incited a critical analysis of the use of chemical inhibitors to regulate LC-FAO and, as we will describe, a careful examination found unexpected effects of etomoxir on T cell differentiation.
| Off-target effects of etomoxir in immune cell differentiation
Since germline deletion of Cpt1a is embryonically lethal, 139 to date much of the evidence that supports its significance in regulating the metabolic program of immune cells has been obtained through the pharmacological inhibition of CPT1 with etomoxir. With a half-maximal inhibitory concentration in the nanomolar range (IC 50 = 10-700 nM), etomoxir is a potent inhibitor of CPT1. [140] [141] [142] [143] Nonetheless, there are important caveats to consider when using this compound. One point is that the concentrations of etomoxir used in most published studies analyzing LC-FAO in immune cells are considerably higher, usually around 200 μM. 70, 71, 130, 131, 134, 144, 145 The possibility of off-target effects in immune cells was first raised in response to publications that reported that etomoxir could interfere with anti-inflammatory (M2) macrophage polarization with IL-4, an effect that was attributed to a reduction of LC-FAO. 145 However, Finkel and colleagues observed that macrophages lacking CPT2, and thus exhibiting reduced LC-FAO, presented no defects in M2 polarization. Furthermore, CPT2deficient macrophages responded to etomoxir treatment in a similar fashion than their WT counterparts. 146 These data suggested that the effects of this compound were mediated not by inhibition of LC-FAO, but rather some other effect of etomoxir on cellular function.
To identify off-target effects of etomoxir in cell differentiation, a recent study by Divakaruni and colleagues used permeabilized cells to measure the effect of etomoxir on substrate specific oxygen consumption, and thus better characterize its influence on mitochondrial metabolism. 143 In accordance with previous findings, 140, 141, 147 the authors reported that etomoxir is a very efficient inhibitor of 
| Mitochondrial oxidation and T mem cell development
Although the aforementioned studies demonstrate that LC-FAO is not crucial for supporting the metabolism of CD8 + T mem cells, ample evidence indicates that sustained mitochondrial oxidation is a metabolic characteristic of the T CM subset of CD8 + T mem cells. 70, 149 CD8 + T mem cells obtained after LmOVA infection were described to have higher SRC and reduced ECAR when compared to T eff cells during the active immune response and thus to rely on OxPhos for ATP production and survival. 69, 70 To support their increased SRC, CD8 + T mem have higher mtDNA/nDNA ratio, mitochondrial mass and expression of key mitochondrial proteins. 70 Moreover, it was suggested that besides providing an efficient energy supply during the periods of quiescence, mitochondrial OxPhos is crucial for the reactivation 
Etomoxir
Coenzyme A of CD8 + T mem cells after secondary challenge because it provides the initial ATP required for the function of hexokinase, an enzyme that phosphorylates glucose and thus catalyzes the first step of glycolysis. 71 Hexokinase activity facilitates the rapid adoption of a glycolytic metabolism and T eff phenotype after TCR stimulation that would contribute to the observed ability of CD8 + T mem to activate and proliferate faster than T n upon stimulation. Correspondingly, inhibition of mitochondrial respiration with low concentrations of oligomycin during re-stimulation of CD8 + T mem cells was found to be detrimental to their activation and proliferation, highlighting the importance of mitochondrial ATP to mediate this process. 71 Recent studies have taken a closer look at mitochondrial morphology during the development of CD8 + T eff and T mem cell responses. It has been demonstrated that in CD8 + T mem cells, mitochondria tend to fuse and develop linear or tubular networks and present tight cristae structure. 130, 131, 144 This morphology has been associated with improved OxPhos due to the arrangement of the proteins of the mitochondrial ETC into tightly packed supercomplexes, which improves electron flow and thus their function. 150, 151 In contrast, mitochondria in CD8 + T eff were described to be diffusely distributed in the cytoplasm and to have a small and punctuate configuration. 70 LmOVA infection. 144 Moreover, treatment with M1 and Mdivi-1 also improved mitochondrial metabolism in activated human CD8 + T cells and increased the expression of T CM markers CD62L and CCR7. 144 These studies provide strong evidence that mitochondrial oxidation is important for the long-term survival and secondary activation of at least a subset of CD8 + T mem cells. However, a reliance on mitochondrial metabolism is not a universal requirement for the establishment of protective memory in vivo. This is illustrated by the deletion of the von Hippel Lindau tumor suppressor protein (VHL), an E3 ubiquitin ligase that induces degradation of HIF1α in normoxic conditions, and whose absence in T cells results in constitutive glycolytic metabolism. 54 Mice with a T cell-specific deletion of VHL have an unaffected capacity to develop protective immune memory after viral infection, despite their prominent glycolytic profile and their inability to upregulate mitochondrial metabolism. 149 Interestingly, VHL-deficient CD8 + T mem cells develop preferentially into a T EM phenotype, further hinting at a relationship between the phenotypical and metabolic heterogeneity of T mem populations. In fact, in mice immunized with LCMV, CD62L hi T CM cells presented a higher SRC than CD62 lo T EM , which underpins the notion that mitochondrial capacity may not be universally related to memory formation, but rather to central memory. 149, 152 Together these data hint at metabolic plasticity and differential fuel usage as key determinants of CD8 + T mem cell development.
| A role for short-and medium-chain fatty acids in T cell metabolism
Mitochondrial respiration can be sustained by different carbon sources, such as pyruvate from glucose, glutamine, and other amino acids and lipids, including not only long-but also medium-and short-chain fatty acids. The complete oxidation of these substrates through the TCA cycle maximizes energy output, and allows quiescent cells to sufficiently satisfy their energy needs with lower amounts of nutrients. Despite this variety, virtually all of the studies analyzing lipid oxidation in T cells have focused on the metabolism of LCFAs such as palmitate or oleate, which require conjugation to carnitine to enter the mitochondria, while ignoring the potential contribution to mitochondrial oxidation of medium-and shortchain acyl groups, which also become substrates in β-oxidation. 153 Unlike LCFAs, there are no known key regulators of the oxidation of MCFAs and SCFAs, whose metabolism is not influenced by CPT1 because they can freely diffuse through the inner mitochondrial membrane. 153 SCFAs in humans are mostly produced by colonic bacteria that ferment dietary fiber and sugars in the gut, and acetate (C 2 ) is also produced by the liver during fasting. SCFAs are readily used for energy by enterocytes in the gut 154 and it has been described that the SCFAs butyrate (C 4 ) and propionate (C 3 ) can inhibit histone deacetylases (HDAC) in colonic T cells. 155 Although oxidation of SCFAs was not evaluated, the study shows that they can enter T cells, and therefore be potentially metabolized. Work by Balmer and colleagues demonstrated that IL-15-derived CD8 + T mem cells actively take up and metabolize acetate in the TCA cycle. 156 Acetate levels in serum increase following pathogen infection, suggesting that acetate may be a usable fuel during immune responses. 156 MCFAs are abundant in milk and can be produced by the liver through peroxisomal oxidation. MCFAs are usually not stored in the adipose tissue, and they are readily available from the circulation in their free form, usually bound to serum albumin, like LCFAs. 153 Unlike LCFAs, they do not require active transport or cytosolic fatty acid-binding proteins (FABP) to enter the cells, and can therefore be oxidized faster than LCFAs. 153 To date, the potential of SCFAs and MCFAs to be oxidized by T cells has not been thoroughly evaluated, though there is clear evidence showing that activated T cells can use certain MCFAs (octanoic and decanoic acid but not dodecanoic acid) to sustain proliferation. 26 
| AMPK and FAO in T eff
Aside from the role of AMPK and oxidative metabolism in promoting metabolic resilience in T mem populations, this kinase is also active and can play a role in T eff cells. Upon TCR stimulation, a transient activation of AMPK in T cells has been reported, which is mediated by phosphorylation by the Ca 2+ -calmodulin-dependent protein kinase kinase (CaMKK), triggered in response to the elevated concentration of cytosolic Ca 2+ that results from TCR signaling. 157 However, the relevance of this process in the activation or function of T cells is not yet fully understood. Importantly, AMPK has a critical function in regulating the phenotype and metabolism of activated cells, in particular upon nutrient deficiency. Deletion of AMPKα1 results in CD8 + T eff cells that have a more activated phenotype and increased production of IFNγ in vivo and in vitro due to their increased mTORC1 activity. 93, 95 In vitro, AMPK-deficient activated T cells deprived of glucose showed reduced cellular ATP concentration and increased mortality. This is attributed partly to their inability to reduce energy expenditure through inhibiting mTORC1 activity and their failure to upregulate glutamine transport and metabolism to increase mitochondrial energy output. 93, 95 In vivo, mice with T cell-specific deletion of AMPK cells had markedly reduced expansion of antigen-specific CD8 + T cells in response to bacterial (L. monocytogenes) or viral (influenza A virus) infections, which reflected a failure of activated cells to persist or survive in inflammatory environments without the energy regulation induced by AMPK. 93 Therefore, AMPK plays an important role in securing the fitness of activated T cells under conditions of metabolic stress. However, there is some controversy around these assertions, as others report that T cell-specific AMPKα1 deletion does not affect the proliferation of antigen-specific cells in response to LmOVA in vivo. 95 Because T cells activated in vitro increase their glycolytic and anabolic metabolism and were observed to downregulate expression of Cpt1a and oxidation of external LCFAs, 24, 25 it has been mostly assumed that CD8 + T eff cells do not require LC-FAO. This is supported by the fact that CD8 + T cells lacking CPT1A are capable of differentiating into T eff cells after TCR stimulation in vitro and after bacterial infection in vivo. 25 However, in vivo studies suggest that OxPhos and FAO can play important roles in disease models that involve chronic stimulation with self-antigen or T cell exhaustion during chronic infection or tumor responses. 19, 158, 159 T cells activated in vivo by MHC alloantigens as in the case of graft-versus-host disease (GVHD) seem to not upregulate Glut1 and display an increased OCR and mitochondrial membrane potential. 160 fatty acids and oxidation of palmitate. 161, 162 Alloreactive cells also increase expression of Cpt1a, Cpt2, and Ppargc1a (PGC1α), an activator of mitochondrial biogenesis and of the nuclear receptor peroxisome proliferative-activated receptor gamma (PPARγ), which induces the uptake and cellular trafficking of lipids. 162, 163 This oxidative metabolism has been associated with the increased expression in allogeneic T cells in GVHD of the inhibitory receptor programmed cell death 1 (PD-1). 164 PD-1 is a member of the CD28 family of receptors that is expressed in activated T cells. Upon ligation by PD-L1 or PD-L2, PD-1 prevents CD28-mediated activation of PI3K and thus of Akt 165 and therefore regulates T cell proliferation, cytokine secretion, and survival. 166 It has been reported that engagement of PD-1 in activated T cells, which causes overall reduction of T cell activation and IFNγ production, also inhibits glycolysis and glutaminolysis, thus shifting the metabolic profile of activated cells. 164, 165, 167 Moreover, PD-1 stimulation during in vitro activation of human CD4 + T cells increased expression of Cpt1a, promoted lipolysis through upregulation of the adipose triacylglycerol lipase (ATGL) and supported oxidation of endogenous fatty acids. 167 Interestingly, signaling from CTLA-4, another inhibitory receptor of the CD28 family which also reduces glycolysis and glutamine transport does not stimulate FAO and lipolysis, suggesting that the upregulation of FAO by PD-1 signaling is not solely a consequence of energy depletion. 167 The uptake of external fatty acids can also be important for T cell activation and proliferation. It has been recently reported that activation of naive and Th2 CD4 + T mem cells is accompanied by an increase in PPARγ expression that is dependent on mTORC1, and supports the uptake of external fatty acids in addition to their endogenous synthesis. 26 where synthesis of NADPH cannot proceed from glucose. 123, [169] [170] [171] Although the relevance of this pathway in primary lymphocytes has, to our knowledge, not been evaluated, it could be also used by T cells to sustain redox balance under metabolic stress.
| LOC ALIZ ATION AND ENVIRONMENT MAY D I C TATE T CELL ME TABOLIC PROG R AMS
Recent studies have now linked the maintenance of specific memory populations to their metabolic profile. As discussed before, most of the work analyzing lipid metabolism in CD8 + T mem cells so far has focused on cells found in lymphoid organs like spleen or lymph nodes, which present a predominantly T CM phenotype. Similarly, CD8 + T mem -like cells generated in vitro with IL-15 resemble T CM and not T EM or T RM . 129 To better understand the metabolic characteristics of CD8 + T RM cells, Pan and colleagues analyzed OT-I T RM cells produced after skin infection with vaccinia virus expressing OVA (rVACV OVA ). 69 In this study, they found that T RM can actively take up and oxidize external palmitate to a higher degree than T n , T EM , or T CM cells and have a higher expression of PPARγ and the fatty acid-binding proteins 4 and 5 (FABP4 and FABP5). FABP4/5 have been described to play an important role in the uptake and intracellular trafficking of FAs in adipocytes, 172 where their expression is promoted by PPARγ. This was found to also be the Specific metabolic characteristics relating to their location and the surrounding metabolic environment have also been assigned to other lymphocyte populations. For instance, Foxp3 + T reg cells make up more than 50% of the CD4 + lymphocytes found in the visceral adipose tissue (VAT) of lean mice. 173 Despite sharing most of their transcriptional profile with T reg cells from the spleen, these VAT T regs have unique metabolic characteristics that are also coordinated by PPARγ, which is highly expressed in these cells. Activation of PPARγ in VAT T reg upregulates the expression of Cpt1a and enzymes related to FA transport, triglyceride synthesis, and lipid-droplet organization. 174 As is the case with tissue resident memory CD8 + T cells, 69 PPARγ is crucial for the development of CD4 + T reg cells in the adipose tissue, but not for those in the spleen or other lymphoid tissues. 174 Similarly, cells in the tumor microenvironment (TME) can find themselves in a metabolically challenging situation. [175] [176] [177] The heavily glycolytic metabolism of most tumors results in glucose depletion in the TME, complemented by reduced oxygen concentration, which impairs the function of the tumor-infiltrating lymphocytes (TILs). 178, 179 In contrast, increased abundance of free FAs produced by the tumor is often observed in the TME, 180 
| MITO CHONDRIAL AND FAT T Y ACID ME TABOLIS M IN H UMAN IMMUNE RE SP ONSE S
The study of individuals with inborn metabolic disorders can provide insights to the metabolic pathways dominating the human immune response. 182 Specific immune deficiencies can be found in individuals with genetic diseases that affect mitochondrial function.
Leukopenia, hypogammaglobulinemia, opportunistic fungal infections, and recurring infections have been reported in patients with mitochondrial disease (MD). 40, 182 In particular, upper respiratory tract infections are observed in 30%-50% of patients with diagnosed MD 40, 183 and it has been reported that vaccination against S. pneumoniae fails to elicit protective immunity in these individuals. 184 Although rare, CPT1 deficiency is observed exclusively for the "liver" CPT1A isoform and it is characterized primarily by hypoglycemic attacks usually associated with fasting. 117, 124, 185 Although most symptoms described for these patients are related to the metabolic defect of LC-FAO in liver and its systemic consequences, an association between carrying a hypomorphic variant of the enzyme and the risk of suffering infections of the lower respiratory tract or acute otitis media was found in children from an Alaskan population with a relatively high incidence of CPT1A-deficiency, although confounding factors preclude reliable conclusions. 186 To improve available information, a clinical study evaluating the immune phenotype in subjects with defects in mitochondrial metabolism is ongoing (clinicaltrials.gov, NCT01780168) and preliminary results indicate that absence of enzymes involved in the mitochondrial β-oxidation of fatty acids does not impair the generation of CD8 + memory responses. 25 In healthy human individuals, there is a progressive accumulation of CD8 + CD28 − T EM cells that has been associated with loss of activity of the deacetylase sirtuin 1 (Sirt1) with age. Like other members of the sirtuin family, Sirt1 is a NAD + -dependent deacetylase that has many roles in modulating metabolism and the immune response. 187 Similar to the differences observed between murine T EM and T CM cells, CD8 + CD28 − cells exhibit increased glycolytic metabolism when compared to CD8 + CD28 + T mem cells or T n , but no differences in their basal or maximal oxygen consumption. 188 Interestingly, treatment of CD8 + CD28 − memory cells with the Sirt1 activator resveratrol lowers glycolytic capacity through activation of the FOXO1 transcription factor that, in addition to regulating the expression of CD62L and CD127, was described to modulate the glycolytic phenotype.
Treatment of naive or CD28 + memory cells with the FOXO1 inhibitor
AS1842856 reduced expression of CD62L and increased granzyme B production in CD28 + T mem cells, presumably through the downregulation of the transcription factor T-bet, 81 while also increasing glycolytic metabolism. Although the exact mechanism through which FOXO1 modulates glycolysis was not defined, the connection between Sirt1 activity, memory phenotype, and metabolism provides an interesting model to comprehend the cues that guide T mem differentiation.
Understanding the metabolic preferences and requirements of T cells can have an important impact in the development of adoptive therapies. Chimeric antigen receptor (CAR-) T cells are transduced to express a synthetic polypeptide that was initially developed to contain an extracellular target binding module, which usually signals through an intracellular TCR domain, and thus can stimulate the natural TCR activation pathway. Second-and third-generation CAR-T cells include the expression of co-stimulatory molecules, such as CD28 or 4-1BB (CD137), which together with the receptor can dramatically improve antitumor activity. The effect of the costimulation is not limited to the immune signaling mediated by these co-receptors, but they can also differentially influence cellular metabolism favoring cellular fitness and improve both effector function and persistence of the CAR-T cell. [189] [190] [191] [192] In particular, it has been found that co-stimulation through 4-1BB is associated with a longer survival and enhanced memory development when compared to CAR-T cells expressing CD28. 189, 192 Interestingly, 4-1BB-expressing cells were also characterized by enhanced mitochondrial biogenesis and metabolism, higher SRC and rates of FAO, as well as a differential expression of metabolic genes favoring FA metabolism over glycolysis, including Cpt1a and Fabp5. 191 Signaling through CD28 intracellular domain was also described to increase Cpt1a expression when compared to T cells harboring only the transgenic antigen-specific receptor. 131 
| CON CLUDING REMARK S
During the last few years, a major interest in understanding the metabolic requirements of immune cells has triggered the establishment of immunometabolism as a new, exciting area of research. Several studies have attempted to describe unique metabolic conditions that favor the development of long-lasting adaptive memory, as this information could be crucial to improve the effectiveness of vaccination or cancer treatment. 176 Taken together, some of these studies had ultimately proposed that CD8 + T mem cells present an exceptional requirement for mitochondrial oxidation of fatty acids to sustain their survival and secondary activation, and identified an important role for CPT1A, an enzyme that can control the rate of LC-FAO, in modulating this adaptation. 70, 71, 106, 131 Due to the absence of sufficient in vivo data and specific genetic models to evaluate this hypothesis, the current paradigm was based on the use of a chemical inhibitor of CPT1, etomoxir, and the analysis of in vitro cultures with IL-15 of antigen-stimulated CD8 + T cells. However, an often-ignored fact is that CPT1A can only modulate the oxidation of FAs with chains longer than 12 carbons, while not affecting the oxidation of shorter FAs that can also provide a source of energy. 67, 153 It is therefore only correct to affirm that CPT1A regulates the oxidation of long-chain fatty acids, and not fatty acids in general, which leaves the potential of SCFAs and MCFAs to support-or even maybe favor-the development of CD8 + T cell memory largely unexplored. Furthermore, it is important to consider the limitations of analyzing memory development with in vitro cultures. It is likely that T cells differentiated in vitro with IL-15 will not share all features of long-lived CD8 + T mem cells obtained after an infection, as IL-15 is not the only factor that influences their development in vivo. In addition, as it has been pointed out, 130 the concentration of nutrients such as glucose, lipids, glutamine, or O 2 that lymphocytes are exposed to in cell culture medium is radically different to that encountered in vivo, and thus limit the application of the information obtained from cell cultures into a real infection setting. 159 New studies targeting Cpt1a in T cells challenge the current model of T mem reliance on LC-FAO for establishing protective memory in vivo. 25 Moreover, careful examination of the effect of etomoxir on T cell metabolism has suggested that, at high concentrations, this compound has multiple off-target effects on mitochondrial metabolism and other cellular processes, which may vary depending on the cellular context and requirements for activation, influencing the differentiation of not only T cells but also other immune subsets such as macrophages. 143, 146 The arguments presented in this review do not preclude an important function for OxPhos in the development and survival of memory cells, or deny the possibility that T cells can profit from the oxidation of lipids to fuel their metabolism under certain circumstances. Instead, we seek to encourage the reader to adopt a more global view of the metabolic requirements of CD8 + T mem cells, considering both cellular state and tissue location. Future research should include use of in vivo and in vitro models that consider cellular location and nutrient that affect T cell metabolism.
In this regard, an interesting topic of research involves the study of the PPAR family of nuclear receptors that have been reported to regulate lipid metabolism in T cells, remarkably in tissue resident cells that might have easier access to fatty acids than glucose or other metabolic substrates. 26, 69, 181, 193, 194 As PPARs have the unique characteristic of being activated by lipid ligands, 168, 194, 195 they could provide a link between environmental availability and the adoption of a lipid-based metabolism. Some of the work presented in this review has started to address this relationship, and we predict that future research will provide exciting new information. Moreover, we have discussed that mitochondrial respiration could favor the survival of memory cells after the resolution of the primary response, but it is also clear that protective immune memory can occur in the event of constitutive glycolysis, at least under certain circumstances. 149 Taken together, although T mem cells can, in many cases, upregulate a certain metabolism to promote their survival, their reliance on this particular metabolic program might not be universal for all T mem subsets, or under all conditions. In the end, the choice of substrate might come down to one thing: enough ATP to get through the day.
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